Boston Medical Sciences

Tokyo-based medical AI startup founded in April 2023 by physicians who teach and research at Harvard Medical School and Massachusetts General Hospital. It develops AIM4CRC, a laxative-free virtual colonoscopy system that pairs colon CT imaging with AI bowel-cleansing and polyp-detection algorithms to remove the prep burden of conventional colon exams. The system completed its Japanese clinical trial, holds US FDA Breakthrough Device Designation (May 2026), and the company is preparing commercialization in Japan and the US.

  • Series B
  • AI/ML
  • Diagnostics
  • Healthtech
  • Medical Devices
  • Healthcare & Life Sciences

1

Round

1

Industry

5

Tags

Nov 13, 2026

Latest raise

Funding activity · 1 round

Raise timeline

  1. Nov 13, 2026

    JPY 35.0M

    Series B

    Led by Beyond Next Ventures

    • Beyond Next Ventures
    • Global Brain Corporation
    • Daiwa House Ventures
    • Nippon Growth Capital Investment Corporation

    Boston Medical Sciences Raises ¥34.98B Series B Led by Beyond Next Ventures

    Boston Medical Sciences Secures Series B Funding Boston Medical Sciences, a Tokyo based medical AI startup, has raised a Series B round totaling ¥34,979,364 (J…

    Read article

Pricing

Research Boston Medical Sciences — then scale the playbook

Public hubs orient you on the raise. Paid plans unlock live AI adoption signals across your market.

Enterprise

Custom pricing for unlimited scale. Let's talk.

Contact sales

Growth plan

For individuals and small teams getting started with AI buyer intelligence.

$149

/month

Features

  • Access to core AI adoption signals
  • 3–5 curated slices per week
  • 30–60 companies / week
  • AI Adoption Score
  • Deal-ready insights (why + pitch angle)
  • Basic filters (recency, slice, score)
  • CSV export
Most popular

Pro plan

For outbound teams and agencies that need more coverage and faster signal cadence.

$249

/month

Features

  • Everything in Growth, plus:
  • Full access to all slices
  • 60–120 companies / week
  • Higher-frequency signal updates
  • Priority / early signals (before Growth)
  • Advanced filters (industry, size, use case)
  • Deeper company insights
  • Faster export + bulk workflows

Act on this raise

See if Boston Medical Sciences is moving on AI

Funding is the starting point. VeilStrat shows whether capital is showing up as hiring, tools, and web activity you can sell into.

© 2026 VeilStrat. All rights reserved.All systems operational